BTMD Stock Analysis: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$1.61
0.13 (8.78%)
▲
5d:
+9.52%
30d:
-28.44%
90d:
-22.22%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BTMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BTMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.89
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$1.80
10.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $1.61, which is considered oversold relative to its 30-day fair value range of $1.56 to $2.39. The stock's valuation (Forward PE: 3.6) is in line with its historical norms (3.3). At these levels, the market is pricing in 3.2% annual earnings growth.
Technical Outlook: Technically, BTMD is showing sideways momentum. Immediate support is located at $1.30, while resistance sits at $1.68. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: BTMD scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.61 (+62.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BTMD is showing sideways momentum. Immediate support is located at $1.30, while resistance sits at $1.68. The stock is showing strong short-term momentum, up 8.8% recently.
Market Sentiment: BTMD scores 85/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.61 (+62.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.56 -
$2.39
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
98.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (85/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.8%)
- BULLISH: Trading 62.2% below Wall St target ($2.61)
- BULLISH: Expecting earnings turnaround to 3.2% growth with -9.5% revenue growth
- CAUTION: Bottoming setup, but lagging the sector by 29% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$1.56 -
$2.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.30
Resistance Level
$1.68
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.58
Wall Street Target
$2.61
(+62.2%)
Revenue Growth (YoY)
-9.5%
Earnings Growth (YoY)
-83.8%
Profit Margin
3.2%
Valuation Premium vs History
+3.2% premium
PE vs Historical
3.6 vs 3.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.2%
(market-implied from PE analysis)
1-Year Target
$1.66
(+3%)
2-Year Target
$1.71
(+7%)
3-Year Target
$1.77
(+10%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$1.63
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 28.6%)
$19.20
(+1092%)
Base:
(SPY PE: 3.6, Growth: 28.6%)
$3.42
(+113%)
Bear:
(PE: 3.0, Growth: 28.6%)
$2.91
(+81%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 9.71 | Current EPS (TTM): $0.14
Bull Case
$2.99
(+86%)
Analyst growth 100.0%, PE expands to 10.7
Base Case
$2.72
(+69%)
Market implied 100.0%, PE stable at 9.7
Bear Case
$0.92
(-43%)
Severe decline -20.0%, PE contracts to 8.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 24, 2026 2:55 AM ET
Data refreshes hourly during market hours. Next update: 3:55 AM
Data refreshes hourly during market hours. Next update: 3:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
